Zenith Drugs Limited Stock Price

NSEI:ZENITHDRUG Community·₹1.1b Market Cap

0 Narratives written by author
0 Comments on narratives written by author
1 Fair Values set on narratives written by author

Create a narrative

ZENITHDRUG Share Price Performance

₹63.15

-45.25 (-41.74%)

₹63.15

-45.25 (-41.74%)

₹63.15

Fri, 7 Nov 25

Share Price₹63.15

ZENITHDRUG Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Snowflake Analysis

Adequate balance sheet with slight risk.

4 Risks

1 Reward

View Full Analysis

Zenith Drugs Limited Key Details

Last Reported Earnings

Mar 31, 2025

Next Reporting Earnings

n/a

: 4.18
: 34.26%
: 5.37%
: 70.0%

View Full Analysis

About ZENITHDRUG

Founded: 1956
Employees: 182
CEO: Sandeep Bhardwaj
WebsiteView website: zenithdrugs.com

Zenith Drugs Limited, together with its subsidiaries, manufactures and trades in branded, generic, and OTC medicines. The company offers a range of pharmaceutical formulations, such as ORS powder, liquid orals, ointments, creams, gels, liquid externals, capsules, and tablets. Its products are indicated for allergology, general analytics, infections, genetics, endocrinology, and microbiology. The company operates in India, Costa Rica, Mauritius, Cambodia, Myanmar, Yemen, Sierra, Leone, Liberia, and Bhutan. Zenith Drugs Limited was incorporated in 1956 and is based in Indore, India.